1. [1] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-1207. [DOI:10.1056/NEJMoa2001316] [PMID] [PMCID]

2. [2] Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. A global treatments for coronaviruses including COVID‐19. J Cell Physiol 2020; 235: 9133-9142. [DOI:10.1002/jcp.29785] [PMID] [PMCID]

3. [3] Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020; 1-4. [DOI:10.1007/s00134-020-05979-7] [PMID] [PMCID]

4. [4] Cao Z, Zhang Q, Lu X, Pfeiffer D, Jia Z, Song H, et al. Estimating the effective reproduction number of the 2019-nCoV in China. ed Rxiv 2020. [DOI:10.1101/2020.01.27.20018952]

5. [5] Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. J Med Virol 2020; 92: 441-447. [DOI:10.1002/jmv.25689] [PMID] [PMCID]

6. [6] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395: 497-506. [DOI:10.1016/S0140-6736(20)30183-5]

7. [7] Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020; 133: 1015-1024. [DOI:10.1097/CM9.0000000000000722] [PMID] [PMCID]

8. [8] Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med 2020; 201: P7-P8. [DOI:10.1164/rccm.2014P7] [PMID]

9. [9] Lei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020; 200236. [DOI:10.1148/radiol.2020200236] [PMID] [PMCID]

10. [10] Malek F, Masoodian N, Samaei A, Gohari A, Reshadat S, Aryan H, et al. Neurologic manifestations of COVID-19: a case series of Iranian patients. J Cell Mol Anesth 5: 271-273. (Persian).

11. [11] Yousefi B, Eslami M. Genetic and structure of novel coronavirus COVID-19 and molecular mechanisms in the pathogenicity of coronaviruses. Rev Med Microbiol 2021. (Persian). [DOI:10.1097/MRM.0000000000000265]

12. [12] Habibi D, Usefi S, Moslemi A. Five-year survival rate and factors affecting the survival of hemodialysis patients. Koomesh 2019; 21: 271-275. (Persian).

13. [13] Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98: 219-227. [DOI:10.1016/j.kint.2020.04.003] [PMID] [PMCID]

14. [14] Rafiq M, Viswanatha G, Mohammed Azeemuddin M, Suryakanth D, Uday Kumar V, Patki P. Cystone, a well-known herbal formulation improves renal function in rats with acute renal failure (ARF) induced by Glycerol intoxication. Iran J Pharmacol Ther 2012; 11: 40-50.

15. [15] Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120: 1883-1887. [DOI:10.1378/chest.120.6.1883] [PMID]

16. [16] Fadaii A, Koohi-Kamali H, Bagheri B, Hamidimanii F, Taherkhanchi B. Prevalence of pulmonary hypertension in patients undergoing hemodialysis. Iran J Kidney Dis 2013; 7: 60.

17. [17] Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep 2020; 5: 580-585. [DOI:10.1016/j.ekir.2020.04.001] [PMID] [PMCID]

18. [18] Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang IK, et al. Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study. Medicine 2014; 93. [DOI:10.1097/MD.0000000000000174] [PMID] [PMCID]

19. [19] Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, et al. Excess deaths attributable to influenza-like illness in the ESRD population. J Am Soc Nephrol 2019; 30: 346-353. [DOI:10.1681/ASN.2018060581] [PMID] [PMCID]

20. [20] Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol 2020; 31: 1409-1415. [DOI:10.1681/ASN.2020040470] [PMID] [PMCID]

21. [21] Up‑regulated S, Up‑regulated E, Hyporeactive M. Overall immune profile and effect of chronic kidney disease on vaccination schedule. Infection 9: 22-25.

22. [22] Beigrezaei S, Heidari M, Tamadon MR. Role of adiponectin in patients with end-stage renal failure. Koomesh 2017; 19: 515-522. (Persian).

23. [23] Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microbes New Infect 2020; 37: 100743. [DOI:10.1016/j.nmni.2020.100743] [PMID] [PMCID]

24. [24] Polverino F. Cigarette smoking and COVID-19: A complex interaction. American journal of respiratory and critical Care Med 2020; 202: 471-472. [DOI:10.1164/rccm.202005-1646LE] [PMID] [PMCID]

25. [25] Collado S, Arenas MD, Barbosa F, Cao H, Montero MM, Villar-García J, et al. COVID-19 in grade 4-5 chronic kidney disease patients. Kidney Blood Press Res 2020; 45: 768-774. [DOI:10.1159/000511082] [PMID] [PMCID]

26. [26] Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int 2020; 98: 1530-1539. [DOI:10.1016/j.kint.2020.07.030] [PMID] [PMCID]

27. [27] Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol 2020; 16: 705-706. [DOI:10.1038/s41581-020-00349-4] [PMID] [PMCID]